CTI BioPharma (CTIC) Balance Sheet

Click line-items for a historical chart and %

Current assets:
Cash and cash equivalents	61.6M
Prepaid expenses and other current assets	1.77M
Total current assets	67.92M
Property and equipment, net	3.22M
Goodwill
Other assets	5.35M
Total assets	76.49M
Current liabilities:
Accounts payable	13.66M
Accrued expenses	22.83M
Current portion of long-term obligations	1.86M
Total current liabilities	46.3M
Long-term obligations, less current portion	3.75M
Total liabilities	63.97M
Commitments and contingencies	0
Common stock purchase warrants
Shareholders' equity:
Common stock, no par value: Authorized shares - 283,333,333 and 200,000,000 at June 30, 2011 and December 31, 2010, respectively Issued and outstanding shares - 175,229,878 and 135,625,216 at June 30, 2011 and December 31, 2010, respectively
Accumulated other comprehensive loss	-6.39M
Accumulated deficit	-2.14B
Total CTI shareholders' equity (deficit)	17.89M
Noncontrolling interest	-5.37M
Total shareholders' equity (deficit)	12.52M
Total liabilities and shareholders' equity	76.49M
7.5% convertible senior notes
Current liabilities:
Convertible debt
5.75% convertible senior notes
Current liabilities:
Convertible debt

Entities mentioned with CTIC